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Introduction
Gastroenteritis (Gi) is one of the most common infec-
tions in children under five years as a community-ac-
quired infection and hospital-acquired infection [1].
Community-acquired Gi generates a variety of problems 
and costs for health care systems, due to visits, hospi-
talizations, laboratory activities, professional services, 
medications and other treatments; gastroenteritis can 
also cause hardship for the families of those infected, 
because of lost working time and reduction in labor 
productivity of the parents [2].
in addition, cases of nosocomially acquired infections 
cause prolongation of hospital stay, and outbreaks of 
Gi may lead to ward closure and, occasionally, even 
closure of the whole hospital [3-5].
the majority of these diseases are viral in origin, with 
rotavirus (rV) and norovirus (nV) being the most com-
mon [1].
For all these reasons, defining correct and efficient in-
fection control measures is very important in preventing 
rV and nV infection, especially when it is necessary to 
avoid the spread of the disease, and to rapidly control 
the outbreaks.
High incidence of rV Gi encouraged research for the de-
velopment of rV vaccine strategies; the first licensed rV 
vaccine (rotaShield, Wyeth - ayerst) against several rV 
diseases have been developed, but have been withdrawn 
because of the slightly increased occurrence of intussus-
ception complications in vaccinated children [6].
intensive work lead to the availability of two new rV 
vaccine tested for safety and protective efficacy in both 
developed and developing countries [7-9].
in developed countries, these vaccines may substan-
tially reduce the number and associated costs of child 
hospitalizations, and clinical visits for acute diarrhoea; 
in developing countries, they could reduce the death 
rate from diarrhoea and improve child survival through 
programmes for children immunisation and diarrhoeal 
disease control [10].
However, rV vaccines cannot be considered the only 
key for decreasing Gi incidence. in fact, economic prob-
lems (especially in the poorest countries of the world) 
and a low compliance to vaccination may determine low 
vaccination coverage of population; besides, it is essen-
tial to consider the necessary period of time (years) for 
obtaining vaccination coverage in paediatric population 
sufficient to minimize the incidence of the disease.
in addition, technical difficulties still present in obtain-
ing an effective vaccine against nV represent further a 
complication for an effective prevention of viral Gi.
Finally, since multiple pathogens are involved in acute 
and severe diarrhea in infants and children, vaccination 
should be considered as a major constituent, but not 
the only one, of the entire prevention measures battery 
required against Gi.
other strategies include health care professionals train-
ing, personnel hygiene, personnel protective equip-
ment, quality standards of health service, antisepsis and 
environmental disinfection; the last one playing a very 
interesting role.
in particular, a correct approach to antisepsis and disin-
fection practices must guarantee the appropriate choice 
of antiseptics and biocides. Selection of products, there-
fore, must be based on experimental evidence of their 
specific efficacy against rV and nV in conditions of 
work practice, to obtain the best possible antimicrobial 
effect on skin, environmental contaminated surfaces and 
objects.
the analysis of preventive measures generally used in 
many health settings, and the review of the properties 
of the main biocides used in hand-antisepsis and in en-
vironmental decontamination, confirm our opinion that 
there is space to implement antisepsis and environmen-
tal disinfection practices, in order to improve control 
measures for viral Gi diseases [4, 11-13].
Discussion
EpidEmiology of gi outbrEaks
Gi is one of the leading causes of mortality and mor-
bidity. it is estimated that worldwide each child under 
5 years has an average of 3.2 episodes of diarrhea per 
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year, and the associated mortality rate is 4,9 deaths per 
1,000 children in this age group [14].
While in industrialized countries infectious diarrhea 
is mainly a problem of morbidity and economic cost, 
in developing countries it is a major cause of mortal-
ity, accounting for about 2.5 million deaths in children 
younger than five years annually (20% of all mortality 
in this group) [15].
Despite the lack of surveillance system has historically 
limited the ability to study the aetiology and the epide-
miology of viral Gi, many recent studies have demon-
strated that nV and rV are a major cause of pediatric Gi 
as community acquired and hospital acquired Gi.
in a recent review, relevant papers published as early 
as 2004 are discussed in the context of viral Gi out-
breaks [16]. all community-based studies confirmed 
that nVs are the most common cause of viral Gi, 
especially in young children; furthermore, rVs were 
ranked among the most important cause when hos-
pitalized children were studied, with nVs coming in 
second place [16].
in addition, nVs have been identified as the cause of 
approximately half of all Gi outbreaks worldwide and 
although infecting all age groups, they cause particu-
larly severe diseases in young children [17].
Parashar et al. estimated that each year rV causes ap-
proximately 111 million episodes of Gi that require home 
care only, 25 million clinics visits, and 2 million hospi-
talizations in children < 5 years of age worldwide [18].
the Pediatric rotavirus European Committee (Pro-
tECt) review’s on pediatric burned of rV disease in 
Europe showed that 40% of the hospitalizations for acute 
Gi in children aged < 5 years old were attributable to rV 
disease with an average cost of € 1,417 per case [19].
in an epidemiological study of health care-associated Gi 
outbreaks in England and Wales, the systematic assess-
ment of Gi outbreaks, carried out by active monitoring of 
Gi, demonstrated that nV was the predominant etiologic 
agent and that rV was the second cause of Gi [20].
italy, unlike other countries, has no specific and con-
stant surveillance system for viral Gi, and laboratory 
diagnosis is rarely performed; thus, in our country, only 
a small number of studies have investigated the preva-
lence and aetiology of viral Gi in children, as a commu-
nity-acquired infection and hospital-acquired infection.
Colomba et al. described the epidemiologic characteris-
tics of acute viral Gi in hospitalised children in Sicily, 
an italian region, for a period of one year, from January 
to December 2003; the results of this study confirmed 
viruses as the most common cause of severe enteric ill-
ness in childhood, with rV and nV playing the main 
role. the researchers, therefore, underline the need of 
a specific surveillance system for viral Gi outbreak and 
the socioeconomic impact of Gi prevention [21].
Moreover, even if nV is considered the leading cause 
of gastroenteritis outbreaks in other countries, in italy 
only a few nV outbreaks have been described [22-24], 
suggesting the magnitude of the introduction of routine 
testing for nV to evaluate the real prevalence of viral Gi 
by different agents.
another survey conducted in italy, analyzing the hos-
pital discharge forms of all children admitted to the 
Paediatric Department of an hospital from 2001 through 
2005, confirmed that rV infections represents an im-
portant cause of hospitalization in children, and is 
responsible for significant costs for the Public Health 
Care System [25].
the high prevalence and incidence of nV and rV infec-
tions is mainly attributed to some characteristics of both 
viruses: low infectious dose, high infectivity, short incu-
bation period, persistence of viruses in the environment 
and multiple routes of transmission (person to person, 
by fecal-oral and aerosol spread, through the vomit as 
well as through ingestion of contaminated food, water 
and environmental surfaces) [16, 26].
Since in institutions housing infants and young chil-
dren, “hand to hand” and “hand to objects” contact is 
frequent, the role of hands, respiratory system and vomit 
in rV and in nV transmission may be complementary 
and synergic.
in the study of isakbaeva et al., the authors described 
an outbreak of nV diarrhea in a community playground; 
they observed a rapid spread of viruses and a high attack 
rate despite good hygienic practices, in absence of obvi-
ous soiling or vomit, consistent with the low dose of the 
virus and the easy mode of transmission [27].
the 5th Edition (2000) of the Block textbook pointed 
out the long environmental survival of rV [28] and this 
was confirmed by studies of other authors [29-32].
in some studies performed in Canada about 30 years 
ago, the persistence of rV for several hours on the hands 
of the examined volunteers supported the viral transfer 
occurring between animate and non-porous inanimate 
surfaces, as vehicles for virus transmission [30].
the high number of hospitalizations of children, the 
high prevalence of nV and rV as cause of Gi, com-
bined with the characteristics of the viruses determine 
a large number of Gi as community-acquired infections 
in nursing homes, residential homes, day care centres, 
dormitories, cruise ships, and schools [4, 33-36], and 
also as explosive outbreaks in hospitals, especially in 
neonatal and pediatric wards.
all reported epidemiologic data emphasize that preven-
tion of viral Gi should be a fundamental practice in 
Public Health worldwide.
antisEpsis and EnvironmEntal disinfEction for thE 
prEvEntion of gi outbrEaks
antisepsis and environmental disinfection procedures are 
important contributions to the prevention of viral Gi, both 
at home and in sanitary and enclosed settings [4, 11, 37]. 
Many enteric viruses can remain viable on inanimate sur-
faces for days and, in particular, infectious rV particles 
have been detected on hands and a variety of surfaces 
and objects. Casual contact can lead to the transfer of 
these viruses from contaminated to clean surfaces and, 
consequently, animate and inanimate surfaces usually 
play a complementary role in the spread of these viruses. 
Hence, prevention of viral Gi outbreaks must take into 
account protocols related to antisepsis and disinfection. in 
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these protocols, selection of appropriate biocides should 
be based on scientific documentation of their efficacy 
against specific virus and on information about their cor-
rect use.
Unfortunately, available literature often shows conflict-
ing results, due to a lack of internationally shared regu-
latory frameworks, indicating experimental standard 
conditions for tests on biocidal efficacy on viruses.
in some European countries, disinfection practioners still 
rely on tests performed on “reference viruses”, as polio-
virus type 1, adenovirus type 5, vaccinia virus strain El-
stree, papovavirus strain 777, and a few others [38, 39].
Consequently, many biocidal products report label 
claims of a general virucidal activity based on data ob-
tained by tests performed on few classes of viruses.
in United States, disinfectants are regulated by U.S. 
Environmental Protection agency (EPa) and U.S. Food 
and Drug administration (FDa). in health-care settings, 
EPa regulates disinfectants that are used on environ-
mental surfaces and FDa regulates liquid chemical 
sterilants/high-level disinfectants used on critical and 
semicritical patient-care devices. CDC provides guid-
ance to practitioners regarding appropriate application 
of EPa and FDa-registered liquid chemical disinfect-
ants and sterilants in health-care settings.
to be labeled as an EPa hospital disinfectant, the prod-
uct must pass association of official analytical Chem-
ists (aoaC) effectiveness tests against three target 
organisms (Salmonella Choleraesuis, Staphylococcus 
Aureus, and Pseudomonas Aeruginosa). Substantiated 
label claims of effectiveness of a disinfectant against 
specific microorganisms other than the test microorgan-
isms are permitted, but not required, on condition that 
the test microorganisms are likely to be present in or on 
the recommended use areas and surfaces [40].
thus, biocidal specific efficacy is evaluated on the basis 
of “specific” tests performed on each virus [41]; when 
the studied virus cannot be cultivated in vivo or in vitro, 
or its handling is unsafe, surrogate virus testing results 
may be accepted [42], as recommended by the Centres 
of Disease Control and Prevention (CDC) [43].
the selection of safe and efficient virucidal biocides 
may be easier if regulatory Frameworks, internationally 
shared, indicates:
• methods for the assessment of virucidal efficacy of 
antiseptics and disinfectants against specific viruses 
(as suggested by the CDC [43]);
• necessity of reliable label claims, based on specific 
virucidal tests performed as indicated in the previous 
paragraph.
Antisepsis
Hand washing is considered as the single most im-
portant procedure for preventing the transmission of 
infections [44]. However, the impact of hand washing 
depends on the type of hand-washing agent selected 
and on the regularity and care of the procedures used 
by health care workers [30].
traditional hand washing with water and liquid soap has 
often proven insufficient.
the advanced Draft Guidelines on Hand Hygiene in 
Health Care of the World Health organization (WHo) 
reviewed a great number of studies about efficacy 
of plain soap, antimicrobial soaps and alcohol-based 
handrubs; the results showed that antiseptic soaps and 
detergents are more efficacious than plain soap and that 
alcohol-based rubs are more efficacious than antiseptic 
detergents.
WHo recommends an alcohol-based formulation for 
hand antisepsis not only for the excellent microbiocidal 
characteristics, fast acting and broad-spectrum activity, 
but also to overcome the lack accessibility to sinks or 
other facilities to perform hand cleansing action that 
require the use of water, to improve compliance with 
hand hygiene by reducing the time required to perform 
it and to reduce costs [45].
Furthermore, in many hospitals, compliance of health 
care workers to hand-washing is approximately 40%, 
and changing hand washing habits in physicians has 
proven difficult.
Hand antisepsis could be improved by increasing the 
number of sinks equipped with liquid antiseptic soap dis-
tributors, and by introducing bed-side dispensers of alco-
holic antiseptic products containing emollients [46, 47].
Most health care workers are still not familiar with the 
evidence that incorporation of glicerol or other emol-
lients into alcohol rinses or gels reduces skin dryness. 
For this reason, some caregivers do not accept new al-
coholic products, even if they show rapid antimicrobial 
activity and asking minimal time commitment [48-52]. 
the rapid activity of these products may be particularly 
useful when health care workers with “apparently” clean 
hands, pass from one patient to the next.
Considering that alcoholic products lose their biocidal 
activity on heavily soiled hands, a preliminary proper 
washing with liquid soap and water is mandatory before 
antiseptic treatment.
Disinfection
the use of chlorine compounds for environmental dis-
infection has been applied and studied for about two 
centuries: only a few years after the discovery of cal-
cium hypochlorite biocidal activity, use of sodium hy-
pochlorite solution (labarraque water – year 1789) was 
suggested for disinfection of surfaces and equipments. 
Sodium hypochlorite is the cheapest and the best avail-
able biocide for many applications in clinical settings 
and at home. it may kill vegetative viruses, bacteria, 
mycobacteria, spores, enveloped and naked fungi and 
protozoa [53].
Dychdala reported that chlorine, in absence of organic 
contaminations, may kill vegetative bacteria, spores, 
fungi and viruses in diluted solutions (100 ppm or less); 
if organic contaminants are present, the loss of chlorine 
biocidal activity is complete when minute amounts of 
chlorine are used [54].
the Public Health laboratory Service Viral Gastro-en-
teritis Working Group listed, as a first control measure 
for nV and rV Gi control, aggressive cleaning of 
surfaces in wards, bathrooms, toilets, and also on bed 
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sheets, carpets and soft furnishing contaminated by 
vomit, faeces, excretions and secretion of human origin. 
after cleaning with detergents, hot water and disposable 
clothes, a freshly prepared solution containing 1,000 
ppm of available chlorine (avCl) in water has be used 
for “standard” disinfection procedures [33].
Some years ago, an experimental study reported that 
5,000 ppm of avCl are able to inactivate human rV 
suspended in liquid faeces and dried on inanimate 
surfaces [55]. More recently, Doultree et al. [56] have 
emphasized the relative resistance of nV to a variety of 
disinfection protocols and have recommended freshly 
reconstituted hypochlorite solution, at a concentration 
of 1,000 ppm, or, if hypochlorite based product is al-
ready in solution, a concentration of 5,000 ppm.
Sattar et al. found a significant reduction in rV con-
tamination on environmental surfaces by using chlorine 
solutions of either 2,000 ppm or 6,000 ppm [57].
Consequently, in many wards, it is an invariable standard 
procedure to routinely disinfect surfaces and instruments 
with no less than 5,000 ppm avCl to guarantee the antivi-
ral activity of chlorine compounds against rV and nV.
in some cases, it will be advantageous to substitute 
sodium hypochlorite with sodium dichloroisocyanurate 
(naDCC), a chlorine compound that maintains the same 
biocidal properties of sodium hypochlorite, while pre-
senting lower corrosivity and susceptibility to proteic 
inactivation [13, 58-61].
When the corrosive, discolouring, or irritating effects of 
chlorine compounds are harmful, a valuable alternative 
in environmental disinfection is represented by phenolic 
biocidal products associated with detergents, which add 
cleaning effect to biocidal properties in “one step” treat-
ment.
the ability of phenolic compounds to inactivate “envel-
oped” (lipophilic) viruses was evidenced by Klein and 
Deforest about 40 years ago (1963). the authors found 
that 5% phenol solution was active against “naked” and 
“enveloped” viruses, and that ortho-phenil-phenol (oPP) 
was highly effective against lipophilic viruses [62].
Sattar et al. have shown the antiviral properties of 
various phenolic derivates on adenovirus type-5, aD-
5, with intermediate sensibility to disinfectants, and 
against cocksakievirus B3, CB-3, selected to represent 
enteroviruses [63].
the same authors compared also the capacity of dif-
ferent biocidal products to interrupt rV spread; their 
results showed that domestic bleach (6% sodium hy-
pochlorite diluted to give 800 ppm free chlorine) and the 
phenolics reduced the virus titer by 97.9% +/- 0.4% and 
95% +/- 5.36%, respectively [64].
in addition to constant efficacy of phenolic derivates on 
rV, proved by various authors, the experiments by Gu-
lati et al. using a feline calicivirus, as nVs “surrogate vi-
rus” [65] drew attention to the phenolics activity against 
small naked viruses previously reported by pertinent 
literature; the results of this study suggested that nV is 
very resistant to commercial disinfectants, but phenolic 
compounds at two to four times their recommended 
concentrations appear to be effective at decontaminating 
environmental surfaces.
to confirm the efficacy of phenolic compounds, as 
demonstrated by the reported experimental studies, 
Centers of Diseases Control and Prevention (CDC) sug-
gested phenolics to prevent spreading of nVs infections 
on cruise ships, in the wake of 21 outbreaks of acute 
Gi occurred during July-December 2002, on 17 cruise 
ships [43].
Finally, Widmer and Frei, considering numerous experi-
mental data, confirm that phenolic compounds associ-
ated with detergents result in products with excellent 
cleaning properties, dissolving proteins and disinfecting 
in one step [66].
therefore, in alternative to chlorine disinfectants, phe-
nolic-detergents products should represent the gold 
standard disinfectants used in prevention of viral Gi.
Conclusions
Chlorine compounds and formulations containing phe-
nolic compounds associated to detergents play an 
important role as environmental disinfectants. Phe-
nolic-detergents should be considered as possible active 
environmental disinfectants in a wide spectrum of viral 
infections including lipophilic viruses, intermediate 
viruses and some naked idrophilic viruses. the use of 
such compounds is strongly recommended by recent 
studies.
Surface decontamination performed by accurate clean-
ing and followed by treatment with chlorine compounds, 
or, as an alternative, done by the use of phenolic com-
pounds associated with detergents (which may clean 
and disinfect in one step) may improve the antimicrobial 
effects in presence of viral Gi, interrupting the risks of 
persistence of infective properties due to faeces, vomit 
and involuntary physical contact.
a better cleaning, antisepsis and disinfection program, 
based on laboratory tests and clinical experiences, will 
result in further improvement in the prevention of viral 
Gi outbreaks, and will provide the best protection to 
patients and health care workers.
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